Reset filter
Palavras-chave
Thérapie médicamenteuse adjuvante ×
Mostrar mais Palavras-chave
Índice
  1. 1. Estudo clínico
  2. 2. Documentação de rotina
  3. 3. Estudos de registo/coortes
  4. 4. Garantia da qualidade
  5. 5. Padrão de dados
  6. 6. Questionário do paciente
  7. 7. Especialidade médica
Modelos de dados selecionados

Deve ter sessão iniciada para selecionar vários modelos de dados e para os transferir ou analisar.

63 Resultados da pesquisa.
Relevância Avaliação Novos primeiro Antigos primeiro

Effect of casoptiant on cardiac conduction as compared to placebo and moxifloxacin 103447 - Non-Serious Adverse Events

- 19/06/2020 - 1 Formulário, 3 Grupos de itens, 13 Elementos de dados, 1 Idioma
Grupos de itens: Administrative, Any Adverse Events?, Non-serious Adverse Event
Study ID: 103447 Clinical Study ID: NKV103447 Study Title:A study to evaluate the effect of casoptiant on cardiac conduction as assessed by 12-lead electrocardiogram as compared to placebo and moxifloxacin Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Sponsor: GlaxoSmithKline Phase: Phase 1 Study Recruitment Status: Completed Generic Name: casopitant Trade Name: Rezonic,Zunrisa; Zunrisa,Rezonic Study Indication: Nausea and Vomiting, Chemotherapy-Induced

Effect of casoptiant on cardiac conduction as compared to placebo and moxifloxacin 103447 - Concomitant Medication

- 19/06/2020 - 1 Formulário, 3 Grupos de itens, 14 Elementos de dados, 1 Idioma
Grupos de itens: Administrative, Concomitant Medications, Concomitant Medications
Study ID: 103447 Clinical Study ID: NKV103447 Study Title:A study to evaluate the effect of casoptiant on cardiac conduction as assessed by 12-lead electrocardiogram as compared to placebo and moxifloxacin Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Sponsor: GlaxoSmithKline Phase: Phase 1 Study Recruitment Status: Completed Generic Name: casopitant Trade Name: Rezonic,Zunrisa; Zunrisa,Rezonic Study Indication: Nausea and Vomiting, Chemotherapy-Induced

Effect of casoptiant on cardiac conduction as compared to placebo and moxifloxacin 103447 - Pharmacogenetic Research

- 19/06/2020 - 1 Formulário, 4 Grupos de itens, 10 Elementos de dados, 1 Idioma
Grupos de itens: Consent for Pharmacogenetic Research, Blood Sample Collection, Withdrawal of Consent, Blood Sample Destruction
Study ID: 103447 Clinical Study ID: NKV103447 Study Title:A study to evaluate the effect of casoptiant on cardiac conduction as assessed by 12-lead electrocardiogram as compared to placebo and moxifloxacin Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Sponsor: GlaxoSmithKline Phase: Phase 1 Study Recruitment Status: Completed Generic Name: casopitant Trade Name: Rezonic,Zunrisa; Zunrisa,Rezonic Study Indication: Nausea and Vomiting, Chemotherapy-Induced

Effect of casoptiant on cardiac conduction as compared to placebo and moxifloxacin 103447 - Status of Treatment Blind

- 18/06/2020 - 1 Formulário, 2 Grupos de itens, 6 Elementos de dados, 1 Idioma
Grupos de itens: Administrative, Status of Treatment Blind
Study ID: 103447 Clinical Study ID: NKV103447 Study Title:A study to evaluate the effect of casoptiant on cardiac conduction as assessed by 12-lead electrocardiogram as compared to placebo and moxifloxacin Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Sponsor: GlaxoSmithKline Phase: Phase 1 Study Recruitment Status: Completed Generic Name: casopitant Trade Name: Rezonic,Zunrisa; Zunrisa,Rezonic Study Indication: Nausea and Vomiting, Chemotherapy-Induced

Effect of casoptiant on cardiac conduction as compared to placebo and moxifloxacin 103447 - Pharmacokinetics - Blood

- 18/06/2020 - 1 Formulário, 9 Grupos de itens, 33 Elementos de dados, 1 Idioma
Grupos de itens: Administrative, Pharmacokinetics - Blood (Session 1), Pharmacokinetics - Blood (Session 1), Pharmacokinetics - Blood (Session 2), Pharmacokinetics - Blood (Session 2), Pharmacokinetics - Blood (Session 3) , Pharmacokinetics - Blood (Session 3), Pharmacokinetics - Blood (Session 4), Pharmacokinetics - Blood (Session 4)
Study ID: 103447 Clinical Study ID: NKV103447 Study Title:A study to evaluate the effect of casoptiant on cardiac conduction as assessed by 12-lead electrocardiogram as compared to placebo and moxifloxacin Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Sponsor: GlaxoSmithKline Phase: Phase 1 Study Recruitment Status: Completed Generic Name: casopitant Trade Name: Rezonic,Zunrisa; Zunrisa,Rezonic Study Indication: Nausea and Vomiting, Chemotherapy-Induced

Effect of casoptiant on cardiac conduction as compared to placebo and moxifloxacin 103447 - Randomisation Number; Investigational Product; Treatment Confirmation

- 17/06/2020 - 1 Formulário, 4 Grupos de itens, 7 Elementos de dados, 1 Idioma
Grupos de itens: Administrative, Randomisation Number, Investigational Product, Treatment Confirmation
Study ID: 103447 Clinical Study ID: NKV103447 Study Title:A study to evaluate the effect of casoptiant on cardiac conduction as assessed by 12-lead electrocardiogram as compared to placebo and moxifloxacin Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Sponsor: GlaxoSmithKline Phase: Phase 1 Study Recruitment Status: Completed Generic Name: casopitant Trade Name: Rezonic,Zunrisa; Zunrisa,Rezonic Study Indication: Nausea and Vomiting, Chemotherapy-Induced

Effect of casoptiant on cardiac conduction as compared to placebo and moxifloxacin 103447 - Continuous Holter ECG

- 17/06/2020 - 1 Formulário, 4 Grupos de itens, 17 Elementos de dados, 1 Idioma
Grupos de itens: Administrative, Predose Continuous 24 hour Holter ECG (Day 1), Continuous 24 hour Holter ECG (Day 3), Continuous 48 hour Holter ECG (Day 5)
Study ID: 103447 Clinical Study ID: NKV103447 Study Title:A study to evaluate the effect of casoptiant on cardiac conduction as assessed by 12-lead electrocardiogram as compared to placebo and moxifloxacin Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Sponsor: GlaxoSmithKline Phase: Phase 1 Study Recruitment Status: Completed Generic Name: casopitant Trade Name: Rezonic,Zunrisa; Zunrisa,Rezonic Study Indication: Nausea and Vomiting, Chemotherapy-Induced

Effect of casoptiant on cardiac conduction as compared to placebo and moxifloxacin 103447 - Electronically Transferred Laboratory Data

- 17/06/2020 - 1 Formulário, 8 Grupos de itens, 15 Elementos de dados, 1 Idioma
Grupos de itens: Administrative, Electronically Transferred Laboratory Data - (Blood) Clinical Chemistry (Screening, Day -1, Day 1-5, Follow-up), Electronically Transferred Laboratory Data - (Blood) Haematology (Screening, Day -1, Day 1-5, Follow-up), Electronically Transferred Laboratory Data - (Urine) Urinalysis (Screening, Day -1, Day 1-5, Follow-up), Electronically Transferred Laboratory Data - (Blood) LFT's only (Day 4), Electronically Transferred Laboratory Data - (Blood) Clinical Chemistry (Unscheduled Assessments) , Electronically Transferred Laboratory Data - (Blood) Haematology (Unscheduled Assessments), Electronically Transferred Laboratory Data - (Urine) Urinalysis (Unscheduled Assessments)
Study ID: 103447 Clinical Study ID: NKV103447 Study Title:A study to evaluate the effect of casoptiant on cardiac conduction as assessed by 12-lead electrocardiogram as compared to placebo and moxifloxacin Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Sponsor: GlaxoSmithKline Phase: Phase 1 Study Recruitment Status: Completed Generic Name: casopitant Trade Name: Rezonic,Zunrisa; Zunrisa,Rezonic Study Indication: Nausea and Vomiting, Chemotherapy-Induced

Effect of casoptiant on cardiac conduction as compared to placebo and moxifloxacin 103447 - Urine Pregnancy Test; Serology

- 15/06/2020 - 1 Formulário, 3 Grupos de itens, 7 Elementos de dados, 1 Idioma
Grupos de itens: Administrative, Urine Pregnancy Test (Complete for Female Subjects Only) (Screening, Day-1, Follow-up), Serology
Study ID: 103447 Clinical Study ID: NKV103447 Study Title:A study to evaluate the effect of casoptiant on cardiac conduction as assessed by 12-lead electrocardiogram as compared to placebo and moxifloxacin Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Sponsor: GlaxoSmithKline Phase: Phase 1 Study Recruitment Status: Completed Generic Name: casopitant Trade Name: Rezonic,Zunrisa; Zunrisa,Rezonic Study Indication: Nausea and Vomiting, Chemotherapy-Induced

Effect of casoptiant on cardiac conduction as compared to placebo and moxifloxacin 103447 - 12-Lead ECG

- 15/06/2020 - 1 Formulário, 4 Grupos de itens, 30 Elementos de dados, 1 Idioma
Grupos de itens: Administrative, 12-Lead ECG (Screening and Follow-up), 12-Lead ECG (Day 3 and 5), 12-Lead ECG (Unscheduled)
Study ID: 103447 Clinical Study ID: NKV103447 Study Title:A study to evaluate the effect of casoptiant on cardiac conduction as assessed by 12-lead electrocardiogram as compared to placebo and moxifloxacin Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Sponsor: GlaxoSmithKline Phase: Phase 1 Study Recruitment Status: Completed Generic Name: casopitant Trade Name: Rezonic,Zunrisa; Zunrisa,Rezonic Study Indication: Nausea and Vomiting, Chemotherapy-Induced

Effect of casoptiant on cardiac conduction as compared to placebo and moxifloxacin 103447 - Vital Signs

- 12/06/2020 - 1 Formulário, 5 Grupos de itens, 25 Elementos de dados, 1 Idioma
Grupos de itens: Administrative, Vital Signs (Screening), Vital Signs (Day 1-4), Vital Signs (Day 5), Vital Signs (Unscheduled Assessments)
Study ID: 103447 Clinical Study ID: NKV103447 Study Title:A study to evaluate the effect of casoptiant on cardiac conduction as assessed by 12-lead electrocardiogram as compared to placebo and moxifloxacin Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Sponsor: GlaxoSmithKline Phase: Phase 1 Study Recruitment Status: Completed Generic Name: casopitant Trade Name: Rezonic,Zunrisa; Zunrisa,Rezonic Study Indication: Nausea and Vomiting, Chemotherapy-Induced

Effect of casoptiant on cardiac conduction as compared to placebo and moxifloxacin 103447 - Vital Signs

- 12/06/2020 - 1 Formulário, 5 Grupos de itens, 25 Elementos de dados, 1 Idioma
Grupos de itens: Administrative, Vital Signs (Screening), Vital Signs (Day 1-4), Vital Signs (Day 5), Vital Signs (Unscheduled Assessments)
Study ID: 103447 Clinical Study ID: NKV103447 Study Title:A study to evaluate the effect of casoptiant on cardiac conduction as assessed by 12-lead electrocardiogram as compared to placebo and moxifloxacin Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Sponsor: GlaxoSmithKline Phase: Phase 1 Study Recruitment Status: Completed Generic Name: casopitant Trade Name: Rezonic,Zunrisa; Zunrisa,Rezonic Study Indication: Nausea and Vomiting, Chemotherapy-Induced

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial